Press Releases
Boehringer Ingelheim and Vétérinaires sans Frontières Germany fight rabies in Kenya
Boehringer Ingelheim launches EURICAN® L4 vaccine, offering outstanding protection against leptospirosis in dogs
Boehringer Ingelheim launches VETMEDIN® Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs
Newsbits
CHMP recommends approval of OFEV® in children and adolescents for the treatment of a range of interstitial lung diseases
Updated data from Beamion LUNG-1 study on zongertinib shows encouraging efficacy in previously treated HER2 mutated lung cancer patients
Boehringer advances oncology research
Stories
Their dogs are their world
Building blocks of our future
Rabies? Not in Mexico!
Media Contacts
Head of Global Media Relations
E-Mail:
harro.ten_wolde@boehringer-ingelheim.com
Phone Number:
+49 (6132) 77-181352
Senior Media Relations Manager
E-Mail:
tereza.urbankova@boehringer-ingelheim.com
Phone Number:
+49 (6132) 77-184817
Senior Media Relations Manager
E-Mail:
mark_william.valentiner@boehringer-ingelheim.com
Tel.: +49 (6132) 77-170136
Media Relations Manager
E-Mail:
valerie-chiara.nestle@boehringer-ingelheim.com
Phone Number:
+49 (7351) 54-175075
Head of Human Pharma Communications
E-Mail:
anthonia.aboyeji@boehringer-ingelheim.com
Phone Number:
+49 (6132) 77-172370
Head of Animal Health Communications
E-Mail:
Heidi.DeWit-Sommerfeld@boehringer-ingelheim.com
Phone Number:
+49 (6132) 77-171799
Head of Innovation Unit Communications
E-Mail: camilla.krogh_lauritzen@boehringer-ingelheim.com
Phone Number: +45 2272 4806
Current Events
Save the Date! Transforming Science Day: 2025
Past Events
Annual Press Conference 2024
Annual Results Press Conference 2023
